# Vaccine-Specific Recommendations (by Date Published)

Advisory Committee on Immunization Practices (ACIP)

Print

Minus

**On This Page**

                - 2024
                - 2023
                - 2022
                - 2021
                - 2020
                - 2019
                - 2018
                - 2017
                - 2016
                - 2015
                - 2014
                - 2013
                - 2012
                - 2011
                - 2010
                - 2009
                - 2008
                - 2007
                - 2006
                - 2005

Consult the ACIP Recommendations page for a complete list of Morbidity and Mortality Weekly Reports (MMWR) on Recommendations of the Advisory Committee on Immunization Practices (ACIP) related to vaccines and immunizations.

Links to final CDC vaccination recommendations (published in MMWR) from Advisory Committee on Immunization Practices (ACIP)

## Listed by Date Published

##  2024

              - Immunization Schedule for Adults Aged 19 Years or Older  Murthy N, Wodi AP, McNally VV, Daley MF, Cineas S.   Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2024 .   Source: *MMWR*. 2024 / 73(1);11–5.
              - Immunization Schedule for Children and Adolescents Aged 18 Years or Younger  Wodi AP, Murthy N, McNally V, Daley MF, Cineas S.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2024 .   Source: *MMWR*. 2024 / 73(1);6–10.

##  2023

              - Polio  Kidd S, Clark T, Routh J, Cineas S, Bahta L, Brooks O.  Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 .   Source: *MMWR*. 2023 / 72(49);1327–1330.
              - Tick-Borne Encephalitis  Hills SL, Poehling KA, Chen WH, Staples JE.  Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 .   Source: *MMWR*. 2023 / 72(RR-5);1–29.
              - COVID-19  Regan JJ, Moulia DL, Link-Gelles R, Godfrey M, Mak J, Najdowski M, et al.  Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023 .   Source: *MMWR*. 2023 / 72(42);1140–1146.
              - RSV  Fleming-Dutra KE, Jones JM, Roper LE, Prill MM, Ortega-Sanchez IR, Ortega-Sanchez DL, et al.  Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 .   Source: *MMWR*. 2023 / 72(41);1115–1122.
              - Pneumococcal  Farrar JL, Gierke R, Andrejko KL, Ayabina D, Zielinski L, Cohen A, et al.  ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023 .   Source: *MMWR*. 2023 / 72(39);1072.
              - COVID-19  Meghani M, Salvesen Von Essen B, Zapata LB, Polen K, Galang RR, Razzaghi H, et al.  COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers — Fall DocStyles Survey, United States, 2022 .   Source: *MMWR*. 2023 / 72(39);1045–51.
              - Pneumococcal  Kobayashi M, Pilishvili T, Farrar JL, Leidner AJ, Gierke R, Prasad N, et al.  Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 .   Source: *MMWR*. 2023 / 72(RR-3);1–39.
              - RSV  Jones JM, Fleming-Dutra KE, Prill MM, Roper LE, Brooks O, Sánchez PJ, et al.  Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023   Source: *MMWR*. 2023 / 72(34);920–925.
              - Flu  Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season    Source: *MMWR*. 2023 / 72(RR-2);1–25.
              - RSV  Melgar M, Britton A, Roper LE, Talbot HK, Long SS, Kotton CN, et al.  Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023    Source: *MMWR*. 2023 / 72(29);793–801.
              - COVID-19 Vaccine Moulia DL, Wallace M, Roper LE, Godfrey M, Rosenblum HG, Link-Gelles R, et al.  Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023    Source: *MMWR*. 2023;72(24);657–62.
              - Immunization Schedule for Adults Aged 19 Years or Older  Murthy N, Wodi AP, McNally V, Cineas S, Ault K.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2023 .   Source: *MMWR*. 2023 / 72(6);141–4.
              - Immunization Schedule for Children and Adolescents Aged 18 Years or Younger  Wodi AP, Murthy N, McNally V, Cineas S, Ault K.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2023 .   Source: *MMWR*. 2023 / 72(6);137–40.

##  2022

              - Measles, Mumps, Rubella  Krow-Lucal E, Marin M, Shepersky L, Bahta L, Loehr J, Dooling K.  Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022    Source: *MMWR*. 2022 / 71(46);1465–70.
              - COVID-19 Vaccine  Rosenblum HG, Wallace M, Godfrey M, Roper LE, Hall E, Fleming-Dutra KE, et al.  Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022    Source: *MMWR*. 2022 / 71(45);1436–41.
              - Cholera Vaccine  Collins JP, Ryan ET, Wong KK, Daley MF, Ratner AJ, Appiah GD, et al.  Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022   Source: *MMWR*. 2022 / 71(RR-2);1–8.
              - Pneumococcal Vaccine  Kobayashi M, Farrar JL, Gierke R, Leidner AJ, Campos-Outcalt D, Morgan RL, et al.  Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022   Source: *MMWR*. 2022 / 71(37);1174–81.
              - Influenza vaccines (2022-23 season)  Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season   Source: *MMWR*. 2022;71(RR-1);1–28.
              - COVID-19 Vaccine  Twentyman E, Wallace M, Roper LE, Anderson TC, Rubis AB, Fleming-Dutra KE, et al.  Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022   Source: *MMWR*. 2022;71(31);988–92.
              - COVID-19 Vaccine  Fleming-Dutra KE, Wallace M, Moulia DL, Twentyman E, Roper LE, Hall E, et al.  Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022   Source: *MMWR*. 2022;71(26);859–68.
              - Smallpox vaccine  Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al.  Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022   Source: *MMWR*. 2022;71(22);734-42.
              - Rabies Vaccine  Rao AK, Briggs D, Moore SM, Whitehill F, Campos-Outcalt D, Morgan RL, et al.  Use of a Modified Preexposure Prophylaxis Vaccination Schedule to Prevent Human Rabies: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022   Source: *MMWR*. 2022;71(18);619–27.
              - Hepatitis B Vaccine Weng MK, Doshani M, Khan MA, Frey S, Ault K, Moore KL, et al.  Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022   Source: *MMWR*. 2022;71(13);477–83.
              - COVID-19 Vaccine Wallace M, Moulia D, Blain AE, Ricketts EK, Minhaj FS, Link-Gelles R, et al.  Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022    Source: *MMWR*. 2022;71(11);416–21.
              - Ebola Vaccine Malenfant JH, Joyce A, Choi MJ, Cossaboom CM, Whitesell AN, Harcourt BH, et al.  Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations — United States, 2021   Source: *MMWR*. 2022;71(8);290–2.
              - Immunization Schedule for Children and Adolescents Aged 18 Years or Younger  Wodi AP, Murthy N, Bernstein H, McNally V, Cineas S, Ault K.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022 .   Source: *MMWR*. 2022;71(7);234–7.
              - Immunization Schedule for Adults Aged 19 Years or Older  Murthy N, Wodi AP, Bernstein H, McNally V, Cineas S, Ault K.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022 .   Source: *MMWR*. 2022;71(7);229–33.
              - Pneumococcal Vaccine  Kobayashi M, Farrar JL, Gierke R, Britton A, Childs L, Leidner AJ, et al.  Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022   Source: *MMWR*. 2022;71(4);109–17.
              - COVID-19 Vaccine Oliver SE, Wallace M, See I, Mbaeyi S, Godfrey M, Hadler SC, et al.  Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021   Source: *MMWR*. 2022;71(3);90-95.
              - Zoster Vaccine Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, et al.  Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022   Source: *MMWR*. 2022;71(3);80–4.

##  2021

              - Dengue Vaccine Paz-Bailey G, Adams L, Wong JM, Poehling KA, Chen WH, McNally V, et al.  Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021   Source: *MMWR*. 2021;70(6);1–16.
              - COVID-19 Vaccine Woodworth KR, Moulia D, Collins JP, Hadler SC, Jones JM, Reddy SC, et al.  Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021   Source: *MMWR*. 2021;70(45);1579–83.
              - COVID-19 Vaccine Mbaeyi S, Oliver SE, Collins JP, Godfrey M, Goswami ND, Hadler SC, et al.  Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021   Source: *MMWR*. 2021;70(44);1545–52.
              - COVID-19 Vaccine Dooling K, Gargano JW, Moulia D, Wallace M, Rosenblum HG, Blain AE, et al.  Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021   Source: *MMWR*. 2021;70(38);1344–8.
              - COVID-19 Vaccine Rosenblum HG, Hadler SC, Moulia D, Shimabukuro TT, Su JR, Tepper NK, et al.  Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021   Source: *MMWR*. 2021;70(32);1094-9.
              - Influenza vaccines (2021-22 season) Grohskopf LA, Alyanak E, Ferdinands JM, Broder KR, Blanton LH, Talbot HK, et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season   Source: *MMWR*. 2021;70(RR-5);1-28.
              - COVID-19 Vaccine Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al.  Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021   Source: *MMWR*. 2021;70(27);977–82.
              - COVID-19 Vaccine  Wallace M, Woodworth KR, Gargano JW, Scobie HM, Blain AE, Moulia D, et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021   Source: *MMWR*. 2021;70(20);749-52.
              - COVID-19 Vaccine  MacNeil JR, Su JR, Broder KR, Guh AY, Gargano JW, Wallace M, et al.  Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021   Source: *MMWR*. 2021;70(17);651-6.
              - Immunization Schedule for Children and Adolescents Aged 18 Years or Younger Woodi AP, Ault K, Hunter P,  McNally V, Szilagyi PG, Bernstein H.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2021   Source: *MMWR*. 2021;70(6);189–92.
              - Immunization Schedule for Adults Aged 19 Years or Older Freedman MS, Ault K, Bernstein H.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2021   Source: *MMWR*. 2021;70(6);193–6.
              - COVID-19 Vaccine Oliver SE, Gargano JW, Scobie H, Wallace M, Hadler SC, Leung J, et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021   Source: *MMWR*. 2021;70(9);329-32.
              - Ebola Vaccine Choi MJ, Cossaboom CM, Whitesell AN, Dyal JW, Joyce A, Morgan RL, et al.  Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020   Source:  MMWR . 2021;70(RR-1);1-12.

##  2020

              - Immunization Schedule for Children and Adolescents Aged 18 Years or Younger Robinson CL, Bernstein H, Poehling K, Romero J, Szilagyi P.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2020   Source: *MMWR*. 2020;69(5);130–2.
              - Immunization Schedule for Adults Aged 19 Years or Older Freedman MS, Hunter P, Ault K, Kroger A.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2020   Source: *MMWR*. 2020;69(5);133–5.
              - COVID-19 Vaccine Dooling K, Marin M, Wallace M, McClung N, Chamberland M, Lee GM, et al.  The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020   Source: *MMWR*. 2020;69(5152);1657-60.
              - COVID-19 Vaccine Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020   Source: *MMWR*. 2020;69(*5152*)1653-6.
              - COVID-19 Vaccine Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020   Source: *MMWR*. 2020;69(50);1922-4.
              - COVID-19 Vaccine  Dooling K, McClung N, Chamberland M, Marin M, Wallace M, Bell B, et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020   Source: *MMWR*. 2020;69(49);1857-9
              - Meningococcal Vaccine  Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, et al.   Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020   Source: *MMWR*. 2020;69(RR-9):1–41.
              - Infuenza vaccines (2020-21 season)  Grohskopf LA, Alyanak E, Broder KR, Blanton LH, Fry AM, Jernigan DB, et al.   Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2020–21 Influenza Season   Source: *MMWR*. 2020;69(RR-8):1–24.
              - Hepatitis A vaccine  Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, et al.   Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020   Source: *MMWR*. 2020;69(RR-5):1–38.
              - DTaP-IPV-Hib-HepB vaccine  Oliver SE, KL Moore.  Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants   Source: *MMWR*. 2020;69(RR-5):136-9.
              - DTaP/Tdap/Td vaccine  Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H.  Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019   Source: *MMWR*. 2020;69(RR-3):77–83.

##  2019

              - Anthrax  Bower WA, Schiffer J, Atmar RL, Keitel WA, Friedlander AM, Liu L, et al.  Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019   Source: *MMWR*. 2019;68(RR-4);1–14.
              - Pneumococcal Vaccines  Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T.  Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices   Source: *MMWR*. 2019;68(46);1069-75.
              - Influenza vaccines (2019-20 season)  Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season   Source: *MMWR*. 2019;68(RR-3);1–21.
              - Human Papillomavirus Vaccination for Adults  Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE.  Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices   Source: *MMWR*. 2019;68(32);698-702.
              - JE vaccine  Hills SL, Walter EB, Atmar RL, Fischer M.  Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices   Source: *MMWR*. 2019;68(RR-2);1-33.
              - Hepatitis A vaccine  Doshani M, Weng M, Moore KL, Romero JR, Nelson NP.  Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness   Source: *MMWR*. 2019;68(6);153-6.
              - Adult immunization schedule  Kim DK, Hunter P.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019   Source: *MMWR*. 2019;68(5)115–8.
              - Child/adolescent immunization schedule  Robinson CL, Bernstein H, Romero JR, Szilagyi P.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019   Source: *MMWR*. 2019;68(5);112–4.

##  2018

              - Hepatitis A Vaccine  Nelson NP, Link-Gelles R, Hofmeister MG, Romero JR, Moore KL, Ward JW, et al.  Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel   Source: *MMWR*. 2018;67(RR-3);1-20.
              - Influenza vaccines (2018-19 season)  Grohskopf LA, Sokolow LZ, Broder KR, Walter EB, Fry AM, Jernigan DB.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season   Source: *MMWR*. 2018;67(RR-3);1-20.
              - Quadrivalent Live Attenuated Influenza vaccines (2018-19 season)  Grohskopf LA, Sokolow LZ, Fry AM, Walter EB, Jernigan DB.  Update: ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season   Source: *MMWR*. 2018:67(22);643-5.
              - DTaP/Tdap/Td vaccine  Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, et al.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)   Source: *MMWR*. 2018:67(RR-2);1-44.
              - HepB Vaccine  Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N.  Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant   Source: *MMWR*. 2018;67(15);455-8.
              - Adult immunization schedule  Kim DK, Riley LE, Hunter P.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2018   Source: *MMWR*. 2018;67(5)158-60.
              - Child/adolescent immunization schedule  Robinson CL, Romero JR, Kempe A, Pellegrini C, Szilagyi P.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2018   Source: *MMWR*. 2018;67(5);156-7.
              - Herpes Zoster vaccine (Shingles)  Dooling KL, Guo A, Patel M, Lee GM, Moore K,Belongia EA, et al.  Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines   Source: *MMWR*. 2018;67(3);103-8.
              - Measles, Mumps and Rubella  Marin M, Marlow M, Moore KL, Patel M.  Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak   Source: *MMWR*. 2018;67(1);33-8.
              - Hepatitis B  Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices   Source: *MMWR*. 2018;67(RR-1);1-33.

##  2017

              - Meningococcal Vaccine  Patton ME, Stephens D, Moore K, MacNeil JR.  Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016    Source: *MMWR*. 2017;66(19);509-13.
              - Oral Cholera vaccine  Wong KK, Burdette E, Mahon BE, Mintz ED, Ryan ET, Reingold AL.  Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine   Source: *MMWR*. 2017;66(18);482-5.
              - Adult immunization schedule  Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2017    Source: *MMWR*. 2017;66(5);136-8.
              - Child/adolescent immunization schedule  Robinson CL, Romero JR, Kempe A, Pellegrini C; Advisory Committee on Immunization Practices (ACIP) Child/Adolescent Immunization Work Group.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2017    Source: *MMWR*. 2017;66(5);134-5.

##  2016

              - Human Papillomavirus vaccination  Meites E, Kempe A, Markowitz LE.  Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices   Source: *MMWR*. 2016;65(49);1405-8.
              - Meningococcal conjugate vaccine  MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IP, Martin SW.  Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016   Source: *MMWR*. 2016;65(43);1189-94.
              - Influenza vaccines (2016-17 season)  Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2016–17 Influenza Season   Source: *MMWR*. 2016;65(RR-5);1-54.
              - Smallpox vaccine  Petersen BW, Harms TJ, Reynolds MG, Harrison LH.  Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015   Source: *MMWR*. 2016;65(10);257-62.
              - Child/adolescent immunization schedules  Kim DK, Bridges CB, Harriman KH, Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group.  Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2016   Source: *MMWR*. 2016;65(4);88-90.
              - Adult immunization schedule  Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group.  Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2016   Source: *MMWR*. 2016;65(4);86-7.

##  2015

              - Meningococcal vaccine   MacNeil JR ,  Rubin L ,  Folaranmi T ,  Ortega-Sanchez  IR,  Patel M ,  Martin SW .  Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults   Source: *MMWR*. 2015:64(41);1171-6.
              - DTaP vaccine  Liang J, Wallace G, Mootrey G.  Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose   Source: *MMWR*. 2015:64(34);948-9.
              - Influenza vaccines (2015-16 season)  Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA.  Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP – U.S., 2015-16 Influenza Season   Source: *MMWR*. 2015:64(30);818-25.
              - PCV13 and PPSV23 vaccines  Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, et al.  Intervals between PCV13 and PPSV23 vaccines: recommendations of the ACIP   Source: *MMWR*. 2015;64(34):944-7.
              - Yellow Fever vaccine  Staples JE, Bocchini JA, Rubin L, Fischer M.  Use of Yellow Fever Vaccine Booster Doses   Source: *MMWR*. 2015;64(23);647-50.
              - Serogroup B Meningococcal vaccine  Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR.  Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the ACIP, 2015   Source: *MMWR*. 2015;64(22);608-12.
              - Typhoid vaccine  Jackson BR, Iqbal S, Mahon B.  Updated Recommendations for the Use of Typhoid Vaccine   Source: *MMWR*. 2015;64(11);305-8.
              - HPV vaccine  Petrosky E, Bocchini JA, Hariri S, Chesson H, Curtis CR, Saraiya M, et al.  Use of 9-Valent Human Papillomavirus (HPV) Vaccine   Source: *MMWR*. 2015;64(11);300-4.
              - Child/adolescent immunization schedules  Strikas RA, ACIP, ACIP Child/Adolescent Immunization Work Group.  ACIP Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2015   Source: *MMWR*. 2015;64(04);93-4.
              - Adult immunization schedule  Kim DK, Bridges CB, Harriman KH, ACIP, ACIP Adult Immunization Work Group.  ACIP Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2015   Source: *MMWR*. 2015;64(04);91-2.

**Top of Page

##  2014

              - Pneumococcal vaccines  Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, et al.  Use of PCV-13 and PPSV-23 vaccine among adults aged 65 and older: recommendations of the ACIP   Source: *MMWR*. 2014;63(37);822-5.
              - HPV vaccine   Human Papillomavirus Vaccination: Recommendations of the ACIP   Source: *MMWR*; August 29, 2014 / 63(RR-5);1-30.
              - Influenza vaccines (2014-15 season)   Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP – U.S., 2014-15 Influenza Season   Source: *MMWR*; August 15, 2014 / 63(32);691-697.
              - Meningococcal vaccine   Use of MenACWY-CRM Vaccine in Children Age 2 Through 23 Months at Increased Risk, Recommendations of the ACIP, 2013   Source: *MMWR*; June 20, 2014 / 63(24);527-30.
              - Hib vaccine recommendations   Prevention and Control of *Haemophilus influenzae* Type b Disease: Recommendations of the ACIP, 2014   Source: *MMWR*; February 28, 2014 / 63(RR-1);1-14.

**Top of Page

##  2013

              - JE vaccine for children   Use of Japanese Encephalitis Vaccine in Children: Recommendations of the ACIP, 2013   Source: *MMWR*; November 15, 2013 / 62(45);898-900.
              - Influenza vaccines (2013-14 season) Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP—United States, 2013–2014   Source: *MMWR*; September 20, 2013 / 62(RR-7);1-43.
              - Updated recommendations for use of VariZIG   Updated Recommendations for Use of VariZIG—United States, 2013   Source: *MMWR*; July 19, 2013 / 62(28);574-6.
              - PCV13 and PPSV23 for ages 6-18 years with immuno. conditions   Use of PCV-13 and PPSV-23 Vaccines Among Children Aged 6–18 Years with Immunocompromising Conditions   Source: *MMWR*; June 28, 2013 / 62(25);521-4.
              - MMR and CRS   Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 Summary: Recommendations of the ACIP   Source: *MMWR*; June 14, 2013 / 62(RR-4);1-34.
              - Influenza interim recommendations Prevention and Control of Influenza with Vaccines: Interim Recommendations of ACIP, 2013   Source: *MMWR*; May 10, 2013 / 62(18);356-6.
              - Meningococcal disease   Prevention and Control of Meningococcal Diseases: Recommendations of ACIP   Source: *MMWR*; March 22, 2013 / 62(RR-2);1-22.
              - Tdap and pregnancy   Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women—ACIP, 2012   Source: *MMWR*; February 22, 2013 / 62(07);131-5.
              - Infant meningococcal vaccination   Infant Meningococcal Vaccination: ACIP Recommendations and Rationale   Source: *MMWR*; January 25, 2013 / 62(03);52-4.

##  2012

              - PCV13 and PPSV23 for adults with immunocompromising conditions   Use of PCV13 and PPSV23 Vaccine for Adults with Immunocompromising Conditions   Source: *MMWR*; October 12, 2012 / 61(40);816-9.
              - Influenza vaccines (2012-13 season)   Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP—United States, 2012–13 Influenza Season   Source: *MMWR*; August 17, 2012 / 61(32);613-8.
              - Tdap for adults age 65 and older   Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older, ACIP 2012   Source: *MMWR*; June 28, 2012 / 61(25);468-70.
              - Licensure of PCV13 for adults age 50 and older   Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older   Source: *MMWR*; June 1, 2012 / 61(21);394-5.
              - New framework (GRADE) for development of evidence-based recommendations New Framework (GRADE) for Development of Evidence-Based Recommendations by the ACIP   Source: *MMWR*; May 11, 2012 / 61(18);327.
              - VariZIG for postexposure prophylaxis of varicella   FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of Varicella   Source: *MMWR*; March 30, 2012 / 61(12);212.

**Top of Page

##  2011

              - Hepatitis B vaccine in adults with diabetes   Policy Note: Use of Hepatitis B Vaccine in Adults with Diabetes Mellitus   Source: *MMWR*; December 23, 2011 / 60(50);1709-11.
              - Use of HPV4 in males   Policy Note: Recommendations on Use of Quadrivalent HPV in Males—ACIP, 2011  Source: *MMWR*; December 23, 2011 / 60(50);1705-8.
              - Health care personnel immunization   Immunization of Health-Care Personnel: Recommendations of ACIP   Source: *MMWR*; November 25, 2011 / 60(RR07);1-45.
              - Herpes Zoster vaccine (Shingles)   Update on Herpes Zoster Vaccine: Licensure for Persons Aged 50 Through 59 Years   Source: *MMWR*; November 11, 2011 / 60(44);1528-8.
              - Tdap and Td vaccines and pregnancy   Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months—ACIP, 2011   Source: *MMWR*; October 21, 2011 / 60(41);1424-6.
              - Intussusception and rotavirus  vaccine   Addition of History of Intussusception as a Contraindication for Rotavirus Vaccination   Source: *MMWR*; October 21, 2011 / 60(41);1427-7.
              - Supplemental Meningococcal   Recommendation of the ACIP for Use of MenACWY-D Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease   Source: *MMWR*; October 14, 2011 / 60(40);1391-2.
              - Influenza vaccines (2011-12 season)   Prevention and Control of Influenza with Vaccines: Recommendations of the ACIP, 2011   Source: *MMWR*; August 26, 2011 / 60(33);1128-32.
              - Meningococcal conjugate vaccine   Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease—ACIP, 2011   Source: *MMWR*; August 5, 2011 / 60(30);1391-2.
              - Booster dose of JE vaccine   Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine—ACIP, 2011   Source: *MMWR*; May 27, 2011 / 60(20);661-3.
              - JE vaccine for children   Update on Japanese Encephalitis Vaccine for Children—United States, May 2011   Source: *MMWR*; May 27, 2011 / 60(20);664-5.
              - General recommendations General Recommendations on Immunization: Recommendations of the ACIP   Source: *MMWR*; January 28, 2011 / 60(RR-2);1-60.
              - Meningococcal Conjugate vaccine   Updated Recommendations for Use of Meningococcal Conjugate Vaccines—ACIP, 2010   Source: *MMWR*; January 28, 2011 / 60(03);72-6.
              - Influenza (Antiviral)   Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of ACIP   Source: *MMWR*; January 21, 2011 / 60(RR-1);1-24.
              - Tdap vaccine   Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Accellular Pertussis (Tdap) Vaccine from the ACIP, 2010 Source: *MMWR*; January 14, 2011 / 60(01);13-5.

**Top of Page

##  2010

              - Pneumococcal (PCV13 and PPSV23) vaccine (infants & children)   Prevention of Pneumococcal Disease Among Infants and Children—Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine   Source: *MMWR*; December 10, 2010 / 59(RR-11);1-18.
              - Pneumococcal (PPSV23) vaccine (adults)   Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using PPSV23   Source: *MMWR*; September 3, 2010 / 59(34);1102-6.
              - Afluria influenza vaccine (2010-2011 season)   Update: Recommendations of ACIP Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11   Source: *MMWR*; August 13, 2010 /59(31);989-92.
              - Influenza (and H1N1) vaccine   Prevention and Control of Influenza with Vaccines   Source: *MMWR*; August 6, 2010 /59(RR-8);1-62.
              - Yellow Fever vaccine   Yellow Fever Vaccine: Recommendations of the ACIP   Source: *MMWR*; July 30, 2010 / 59(RR-7);1-27.
              - Anthrax vaccine   Use of Anthrax Vaccine in the United States   Source: *MMWR*; July 23, 2010 / 59(RR-6);1-30.
              - Human Papillomavirus (HPV2 and HPV4) vaccine                  - Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in **Females** and Updated HPV Vaccination Recommendations from the ACIP   Source: *MMWR*; May 28, 2010 / 59(20);626-9.
                - Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the ACIP   Source: *MMWR*; May 28, 2010 / 59(20);630-2. 
              - Measles, Mumps, Rubella and Varicella (MMRV) vaccine   Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine Recommendations of the ACIP   Source: *MMWR*; May 7, 2010 / 59(RR-3);1-12.
              - Influenza vaccine (Fluzone high-dose)   Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use—United States, 2010   Source: *MMWR*; April 30, 2010 / 59(16);485-6.
              - Rabies vaccine   Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies Recommendations of the ACIP   Source: *MMWR*; March 19, 2010 / 59(RR-2);1-9.
              - Meningococcal Conjugate vaccine (Menveo)   Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use—ACIP, 2010   Source: *MMWR*; March 12, 2010 / 59(09);273.
              - 13-Valent Pneumococcal Conjugate vaccine (PCV13)   Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children—ACIP, 2010   Source: *MMWR*; March 12, 2010 / 59(09);258-61.
              - Japanese Encephalitis vaccines   Japanese Encephalitis Vaccines Recommendations of the ACIP   Source: *MMWR*; March 12, 2010 / 59(RR-1);1-27.

**Top of Page

##  2009

              - Influenza A (H1N1) vaccine (2009)   Use of Influenza A (H1N1) 2009 Monovalent Vaccine: Recommendations of the ACIP, 2009   Source: *MMWR*; August 28, 2009 / 58(RR-10);1-8.
              - Influenza vaccines (2009) Prevention and Control of Influenza: Recommendations of ACIP, 2009   Source: *MMWR*; July 31, 2009 / 58(RR-8);1-52.
              - Rotavirus vaccine   Prevention of Rotavirus Gastroenteritis Among Infants and Children Recommendations of the ACIP   Source: *MMWR*; February 6, 2009 / 58(RR-2);1-25.

##  2008

              - Tdap vaccine and pregnancy   Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants   Source: *MMWR*; May 30, 2008 / 57(RR-4);1-47,51.                  - Appendix A – Summary
                - Appendix B – Abbreviations Used in This Report 
              - Herpes Zoster (Shingles) vaccine   Prevention of Herpes Zoster: Recommendations of the ACIP   Source: *MMWR*; June 6, 2008 / 57(05);1-30.

##  2007

              - Varicella vaccines   Prevention of Varicella: Recommendations of the ACIP   Source: *MMWR*; June 22, 2007 / 56(RR-4);1-40.
              - HPV vaccine   Quadrivalent Human Papillomavirus Vaccine: Recommendations of the ACIP   Source: *MMWR*; March 23, 2007 / 56(RR-2);1-24.

**Top of Page

##  2006

              - Tdap vaccine (adults)   Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine   Source: *MMWR*; December 15, 2006 / 55(RR-17);1-33.
              - Hepatitis B vaccine (adults)   A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States   Source: *MMWR*; December 8, 2006 / 55(RR-16);1-25.
              - Rotavirus vaccine   Prevention of Rotavirus Gastroenteritis Among Infants and Children   Source: *MMWR*; August 11, 2006 / 55(RR-12);1-13.
              - Hepatitis A vaccine (children) Prevention of Hepatitis A Through Active or Passive Immunization   Source: *MMWR*; May 19, 2006 / 55(RR-7);1-23.
              - Tdap vaccine (adolescents)   Preventing Tdap Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines   Source: *MMWR*; March 24, 2006 / 55(RR-3)1-34.

**Top of Page

##  2005

              - Hepatitis B vaccine   A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States   Source: *MMWR*; December 23, 2005 / 54(RR-16);1-23.

**Top of Page

                - A New Product (VariZIGTM) for Postexposure Prophylaxis of Varicella Available Under an Investigational New Drug Application Expanded Access Protocol   Source: MMWR; March 3, 2006 / 55(08);209-10.
                - Consult the American Academy of Pediatrics site for the current  Status of Licensure and Recommendations for New Vaccines

January 12, 2024
National Center for Immunization and Respiratory Diseases

- Facebook
- Twitter
- LinkedIn
- Syndicate